The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

Pharmacy benefit managers "are raking in billions in excess revenue—$7.3 billion over just five years—while squeezing ...

The US Federal Trade Commission has prepared a lawsuit against tractor giant Deere & Co. alleging the company’s agricultural ...

Margin expansion at Express Scripts, Caremark and Optum Rx increased by $336 million between 2017 and 2021, officials say.

Independent contractors and gig workers who organize or collectively bargain are shielded from antitrust liability under a ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

While Greystar maintains it has been proactive in improving fee disclosures and promoting transparency, the company noted the ...

The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...

On Friday, January 10, 2025, the Chamber of Commerce, Business Roundtable, American Investment Council, and Longview Chamber of Commerce filed ...

It takes effect Tuesday but its fate is already in doubt. The new FTC rule faces legal challenges and possible opposition ...